Funding
Turn ideas into impact
Show Me
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-056
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-055
Due: December 23, 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 – Clinical Trials Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-016
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products – Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-018
Due: December 23, 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-019
Due: December 23, 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-020
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products – Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-017
Due: December 31, 2027
NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Type
Cooperative Agreement
Source
Federal
Opp Number
P23AS00132
Due: January 4, 2028
DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0003
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?